Announcements Trials
Browse Landscape

Status

Completed 2

Sponsor Class

OTHER 49INDUSTRY 26NETWORK 2NIH 1

Study Type

Interventional 40Observational 2

Sponsor

Cancer Type

Thoracic 2

Conditions

Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Adenocarcinoma, Bronchiolo-Alveolar 2Adenocarcinoma of Lung 2

Interventions

Gene Expression Profiling 74Polymerase Chain Reaction 44Microarray Analysis 40Amplified Fragment Length Polymorphism Analysis 37Immunohistochemistry 35Flow Cytometry 30Reverse Transcriptase Polymerase Chain Reaction 22DNA Methylation 16Blotting, Western 15Cytogenetic Analysis 14Base Sequence 12Psychiatric Rehabilitation 11In Situ Hybridization, Fluorescence 10Immunologic Techniques 9Enzyme-Linked Immunosorbent Assay 7Mental Status and Dementia Tests 6Comparative Genomic Hybridization 6Watchful Waiting 5Specimen Handling 5Pharmacogenomic Testing 5Mass Spectrometry 5Gene Rearrangement 5Chromosome Mapping 5Surveys and Questionnaires 4Surgical Procedures, Operative 4Rituximab 4Paclitaxel 4Interviews as Topic 4In Situ Hybridization 4Immunoenzyme Techniques 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
NETWORK × Observational × Bevacizumab × Clear all
NCT00898417 2017-05-19

Biomarker Study of Blood Samples From Patients With Non-Small Cell Lung Cancer Treated With Carboplatin and Paclitaxel With or Without Bevacizumab

Eastern Cooperative Oncology Group

Completed
90 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT00900172 2017-05-19

Study of Blood and Tissue Samples From Patients With Locally Advanced, Metastatic, or Recurrent Non-Small Cell Lung Cancer Treated With Bevacizumab, Carboplatin, and Paclitaxel

Eastern Cooperative Oncology Group

Completed
180 enrolled
Thoracic

Adenocarcinoma of Lung, Adenocarcinoma, Bronchiolo-Alveolar, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡